MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Attenuation reduction significance between OCAs. by Mathew Loren (6689951)

Attenuation reduction significance between time points. by Mathew Loren (6689951)

“…<p>Immersion in each optical clearing agent led to a significant reduction in attenuation coefficient. * and *** denote p<0.05 and p<0.001, respectively. …”

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

APRIL/BLyS blockade resulted in significant reduction of anti-nuclear autoantibodies (ANA). by Natalie M. Bath (6316517)

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Comparison of CT scan protocol, radiation dose and contrast agent volume reduction. by Min Su Park (744914)

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Overview of the agent-based model. by Hiroyasu Inoue (709412)

Ranking of infection control interventions (1–8) by percent reduction in HA-CDI per 10,000 patient days, for the H-ABM and the generic model; with 1 representing the greatest reduc... by Elizabeth Scaria (9531765)